BRAIN TARGETING FOR A CENTRAL NERVOUS SYSTEM ACTING DRUG

Main Article Content

Fahad Abdullah Ajab Alshkarah
Salem Abdul Rahman Salem Al-Ghamdi
BADER Mubarak Saleh Alhunayni
Mohammed Ayed Matar Almutairi
Mohammed Saeed Mesfer Alwadai
Hadi Aidh Mesfer AlQahtani

Keywords

Brain targeting, Central nervous system,, Drug delivery, Neurological disorders, Drug efficacy

Abstract

Brain targeting for central nervous system acting drugs is essential for the effective treatment of neurological disorders. This essay explores the methods and techniques used to target drugs specifically to the brain and central nervous system, with a focus on enhancing drug delivery and efficacy. The importance of precise targeting in improving treatment outcomes and reducing side effects is discussed, along with current challenges and future directions in the field.

Abstract 60 | pdf Downloads 16

References

1. Pardridge WM. Blood-brain barrier drug targeting: the future of brain drug development. Mol Interv. 2003;3(2):90-105.
2. Hynynen K, McDann N, et al Focused ultrasound for blood-brain barrier disruption and enhanced drug.surg Focus.2012;32(1):E4.
3. Saraiva C, Praça C, et al.oparticle-mediated brain drug delivery: Overcoming blood-brain barrier challenges. Curr Opin Pharmacol. 2016;18:-3.
4. Agrawal M, Saraf S, et al. Recent strategies and advances in the fabrication of nano lipid carriers and their application towards brain targeting. J Control Release. 2014;185:88-100.
5. Lochhead JJ, Thorne RG. Intranasal delivery of biologics to the central nervous system. Adv Drug Deliv Rev. 2012;64(7):614-628.
6. Piazza J, Hoare T, et al. Nanoparticle delivery of sensitizers in photodynamic therapy for targeted brain cancer treatment. Biotechnol Bioeng. 2013;110(8):2295-2302.
7. Pardridge WM. The blood-brain barrier: bottleneck in brain drug development. NeuroRx. 2005;2(1):3-14.
8. Gao X, Chen J, et al. In situ catechol-functionalized bacterial cellulose nanofibrous scaffold as a versatile and biomimetic matrix for versatile localized drug delivery. Adv Mater. 2014;26(5):429-432.
9. Allegra S, Fattebert J, et al. Enhanced brain delivery of vasoactive intestinal peptide analogs through conjugation to a blood-brain barrier drug targeting system. J Pharmacol Exp Ther. 2009;331(1):408-416.
10. Gabathuler R. Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases. Neurobiol Dis. 2010;37(1):48-57.

Most read articles by the same author(s)